Found 6 matching trials
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer PHASE2 Study design: Prospective, single-arm, single-center phase II clinical stud...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma PHASE2 This is a prospective, single-center, single-arm, phase II clinical study. ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies. NA Based on the interaction between radiation therapy and immunotherapy and th...
Show More Location
Zhengjiang Cancer Hospital
Learn More & Join Trial
Sintilimab Combined With GEMOX ± IBI305 (Bevacizumab Biosimilar) Versus GEMOX in Advanced Intrahepatic Cholangiocarcinoma PHASE2 A randomized controlled, phase II clinical trial is designed to compare the...
Show More Location
Tianjin Medical University Cancer Institute & Hospital
Learn More & Join Trial
Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer PHASE2 Study design: Prospective, single-arm, single-center phase II clinical stud...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Exploration of Sintilimab + Bevacizumab + AG Chemotherapy as First-Line Treatment for Unresectable Advanced/Metastatic Cholangiocarcinoma PHASE2 Evaluation of Efficacy and Safety of Sintilimab Plus Bevacizumab and AG Reg...
Show More Location
the Second Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial